Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-5524
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKaps, Leonard-
dc.contributor.authorLabenz, Christian-
dc.contributor.authorGrimm, Daniel-
dc.contributor.authorSchwarting, Andreas-
dc.contributor.authorGalle, Peter R.-
dc.contributor.authorSchreiner, Oliver-
dc.date.accessioned2021-01-20T08:52:59Z-
dc.date.available2021-01-20T08:52:59Z-
dc.date.issued2020-
dc.identifier.urihttps://openscience.ub.uni-mainz.de/handle/20.500.12030/5528-
dc.description.abstractThe biological anakinra appears promising to halt cytokine storm syndrome seen in severe courses of COVID‐19. However, immunosuppression with anakinra may facilitate sepsis, necessitating continuous screening for bacterial superinfections.en_GB
dc.description.sponsorshipDFG, Open Access-Publizieren Universität Mainz / Universitätsmedizin Mainzde
dc.language.isoengde
dc.rightsCC-BY*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subject.ddc610 Medizinde_DE
dc.subject.ddc610 Medical sciencesen_GB
dc.titleTreatment of cytokine storm syndrome with IL‐1 receptor antagonist anakinra in a patient with ARDS caused by COVID‐19 infection : a case reporten_GB
dc.typeZeitschriftenaufsatzde
dc.identifier.doihttp://doi.org/10.25358/openscience-5524-
jgu.type.contenttypeScientific articlede
jgu.type.dinitypearticleen_GB
jgu.type.versionPublished versionde
jgu.type.resourceTextde
jgu.organisation.departmentFB 04 Medizinde
jgu.organisation.number2700-
jgu.organisation.nameJohannes Gutenberg-Universität Mainz-
jgu.rights.accessrightsopenAccess-
jgu.journal.titleClinical Case Reportsde
jgu.journal.volume8de
jgu.journal.issue12de
jgu.pages.start2989de
jgu.pages.end2993de
jgu.publisher.year2020-
jgu.publisher.nameWileyde
jgu.publisher.placeChichesterde
jgu.publisher.urihttps://doi.org/10.1002/ccr3.3307de
jgu.publisher.issn2050-0904de
jgu.organisation.placeMainz-
jgu.subject.ddccode610de
Appears in collections:JGU-Publikationen

Files in This Item:
File Description SizeFormat 
kaps_leonard-treatment_of_c-20210104145006284.pdf354.04 kBAdobe PDFView/Open